Effects of treatment with fluoride on bone mineral density and fracture risk - a meta-analysis

@article{Vestergaard2007EffectsOT,
  title={Effects of treatment with fluoride on bone mineral density and fracture risk - a meta-analysis},
  author={Peter Vestergaard and Niklas Rye J{\o}rgensen and Peter Schwarz and L. Mosekilde},
  journal={Osteoporosis International},
  year={2007},
  volume={19},
  pages={257-268}
}
SummaryFluoride has fallen into discredit due to the absence of an anti-fracture effect. However, in this meta-analysis, a fracture reducing potential was seen at low fluoride doses [≤20 mg fluoride equivalents (152 mg monofluorophosphate/44 mg sodium fluoride)]: OR = 0.3, 95% CI: 0.1–0.9 for vertebral and OR = 0.5, 95% CI: 0.3–0.8 for non-vertebral fractures.IntroductionFluoride is incorporated into bone mineral and has an anabolic effect. However, the biomechanical competence of the newly… 
Low-dose fluoride in postmenopausal women: a randomized controlled trial.
TLDR
Low-dose fluoride does not induce substantial effects on surrogates of skeletal health and is unlikely to be an effective therapy for osteoporosis.
Comprehensive Management of Osteoporotic Thoracic and Lumbar Vertebral Compression Fractures
TLDR
The 10-year probability of FF can be assessed using the Fracture Risk Assessment Tool (FRAX), which stratifi es risk according to ethnicity, age, sex, weight, height, fracture history, and family history of femoral neck/hip fracture.
Osteoporosis and trace elements--an overview.
  • J. Aaseth, G. Boivin, O. Andersen
  • Medicine
    Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements
  • 2012
TLDR
Osteoporosis is a multi-factorial disease with potential contributions from genetic, endocrine functional, exercise related and nutritional factors, of particular considerations are calcium, vitamin D, fluoride, magnesium and other trace elements.
Do the other nutrients except calcium and vitamin D prevent the incidence of osteoporosis
TLDR
In conclusion, risk of osteoporosis incidence may be diminished with an adequate and balanced diet containing variety of foods to meet needs and a healthy lifestyle.
Intravenous ibandronate or sodium-fluoride--a 3.5 years study on bone density and fractures in Crohn's disease patients with osteoporosis.
TLDR
Keeping in mind bisphosphonates as a standard of osteoporosis care that reduce fracture-rate, data do not have for sodium-fluoride, CD patients with osteoporeosis can be treated safely with i.v. ibandronate.
Glucocorticoid-induced osteoporosis: treatment update and review
TLDR
Parathyroid hormone and zoledronic acid have emerged as exciting new options for the treatment of GIO and both therapies have been found to result in gains in BMD at the spine and hip that are either noninferior or superior to those seen with oral bisphosphonate therapy.
Clinical assessment of fracture risk and novel therapeutic strategies to combat osteoporosis.
TLDR
Improved assessment of fracture risk, combined with tailored therapies for at-risk patients, will increase the number of patients who receive appropriate bone-sparing therapies and improve the ways in which skeletal health can be maintained and osteoporosis can be treated.
Treatment of postmenopausal osteoporosis in women: a systematic review.
TLDR
A search for randomized clinical trials in PubMed and LILACS that presented results for bone mineral density, incidence of vertebral fractures, and adverse effects for osteoporosis found 32 articles that met the review's inclusion criteria.
Clinical and radiographic evaluation of effect of risedronate 5 mg as an adjunct to treatment of chronic periodontitis in postmenopausal women (12-month study)
TLDR
Bisphosphonate therapy as an adjunct to scaling and root planing may have significant beneficial clinical effects on the periodontium of postmenopausal women with moderate to severe chronic periodontitis.
The incorporation of fluoride and strontium in hydroxyapatite affects the composition, structure, and mechanical properties of human cortical bone.
TLDR
Osteoporosis treatment with strontium and fluoride showed positive effects on the microstructure and the mechanical characteristics of bone in comparison to treatment-naïve osteoporotic bone.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 55 REFERENCES
Fluoride for the Treatment of Postmenopausal Osteoporotic Fractures: A Meta-Analysis
TLDR
Although fluoride has an ability to increase bone mineral density at the lumbar spine, it does not result in a reduction in vertebral fractures, and increasing the dose of fluoride increases the risk of nonvertebral fractures and gastrointestinal side effects without any effect on the vertebral fracture rate.
Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk – a meta-analysis
TLDR
It is revealed that PTH alone or in combination with antiresorptive drugs would appear to be able to reduce the risk of vertebral and non-vertebral fractures and to increase spine and perhaps hip BMD.
Effect of sodium fluoride on the prevention of corticosteroid-induced osteoporosis
TLDR
It is concluded that in Cs-treated patients without established osteoporosis NaF prevents bone loss in the lumbar spine but does not have a positive effect on the BMD of the hips.
The Effect of Sodium Monofluorophosphate plus Calcium on Vertebral Fracture Rate in Postmenopausal Women with Moderate Osteoporosis
TLDR
Low-dose fluoride (sodium monofluorophosphate [MFP]) plus calcium in a 4-year, randomized, double-blind, controlled clinical trial in postmenopausal women with moderately low bone mineral density (BMD) of the spine found to be useful in patients with mild to moderate osteoporosis.
Fluoride Salts are no Better at Preventing New Vertebral Fractures than Calcium-Vitamin D in Postmenopausal Osteoporosis: The FAVOStudy
TLDR
It is concluded that flouride-Ca-D regimen was no more effective that Ca-D supplements for the prevention of new vertebral fractures in women with postmenopausal osteoporosis.
Fluoride for treating postmenopausal osteoporosis.
TLDR
Although fluoride has an ability to increase BMD at lumbar spine, it does not result in a reduction of vertebral fractures and in increasing the dose of fluoride, one increases the risk of non-vertebral fracture and gastrointestinal side effects without any effect on the vertebral fracture rate.
Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis.
TLDR
It is concluded that fluoride therapy increases cancellous but decreases cortical bone mineral density and increases skeletal fragility, and the fluoride-calcium regimen was not effective treatment for postmenopausal osteoporosis.
Avoidance of Vertebral Fractures in Men with Idiopathic Osteoporosis by a Three Year Therapy with Calcium and Low-Dose Intermittent Monofluorophosphate
TLDR
Early treatment of idiopathic osteoporosis in the male using the fluoride-calcium regimen tested can improve cancellous and cortical bone density, reduce the incidence of vertebral fractures and attenuate back pain.
Fluoride therapy in prevention of rheumatoid arthritis induced bone loss.
TLDR
The results showed that fluoride therapy was well tolerated and increased vertebral bone mass in patients with RA, and sodium fluoride (40 mg/day) in preventing rheumatoid arthritis induced bone loss and osteoporosis.
Treatment of Postmenopausal Osteoporosis with Slow-Release Sodium Fluoride: Final Report of a Randomized Controlled Trial
TLDR
The cyclical, intermittent use of a lower dose of less bioavailable, slow-release sodium fluoride and continuous supplementation with calcium citrate has been shown to maintain serum fluoride concentrations within the narrow therapeutic window and to stimulate the formation of normally mineralized bone with an improved intrinsic quality of cancellous bone.
...
1
2
3
4
5
...